Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Gene immunotherapy of colon carcinoma with IL-2 and IL-12 using gene electrotransfer
Avtorji:ID Komel, Tilen (Avtor)
ID Omerzel, Maša (Avtor)
ID Kamenšek, Urška (Avtor)
ID Žnidar, Katarina (Avtor)
ID Lampreht Tratar, Urša (Avtor)
ID Kranjc Brezar, Simona (Avtor)
ID Dolinar, Klemen (Avtor)
ID Pirkmajer, Sergej (Avtor)
ID Serša, Gregor (Avtor)
ID Čemažar, Maja (Avtor)
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1422-0067/24/16/12900
 
.pdf PDF - Predstavitvena datoteka, prenos (6,92 MB)
MD5: 8C2E5CE838ECAE708FAF67628D645AB9
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Povzetek:Gene immunotherapy has become an important approach in the treatment of cancer. One example is the introduction of genes encoding immunostimulatory cytokines, such as interleukin 2 and interleukin 12, which stimulate immune cells in tumours. The aim of our study was to determine the effects of gene electrotransfer of plasmids encoding interleukin 2 and interleukin 12 individually and in combination in the CT26 murine colon carcinoma cell line in mice. In the in vitro experiment, the pulse protocol that resulted in the highest expression of IL-2 and IL-12 mRNA and proteins was used for the in vivo part. In vivo, tumour growth delay and also complete response were observed in the group treated with the plasmid combination. Compared to the control group, the highest levels of various immunostimulatory cytokines and increased immune infiltration were observed in the combination group. Long-term anti-tumour immunity was observed in the combination group after tumour re-challenge. In conclusion, our combination therapy efficiently eradicated CT26 colon carcinoma in mice and also generated strong anti-tumour immune memory.
Ključne besede:colon carcinoma, gene electrotransfer, gene immunotherapy
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Poslano v recenzijo:20.07.2023
Datum sprejetja članka:15.08.2023
Datum objave:17.08.2023
Založnik:MDPI
Leto izida:2023
Št. strani:str. 12900-1-12900-25
Številčenje:Vol. 24, no. 16
Izvor:Basel, Switzerland
PID:20.500.12556/DiRROS-18508 Novo okno
UDK:602.6/.7
ISSN pri članku:1422-0067
DOI:10.3390/ijms241612900 Novo okno
COBISS.SI-ID:162334211 Novo okno
Avtorske pravice:by Authors
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 25. 8. 2023;
Datum objave v DiRROS:21.03.2024
Število ogledov:119
Število prenosov:55
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:International journal of molecular sciences
Skrajšan naslov:Int. j. mol. sci.
Založnik:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:17.08.2023

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:rak debelega črevesa, elektroprenos genov, genska imunoterapija


Nazaj